These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Statins as cardioprotective agents. Piskur JR; Stone NJ Am J Manag Care; 2002 Jun; 8(9 Suppl):25-9. PubMed ID: 12099325 [No Abstract] [Full Text] [Related]
6. Squalene synthase inhibitor lapaquistat acetate: could anything be better than statins? Liao JK Circulation; 2011 May; 123(18):1925-8. PubMed ID: 21518979 [No Abstract] [Full Text] [Related]
7. Beyond statins: new lipid lowering strategies to reduce cardiovascular risk. Noto D; Cefalù AB; Averna MR Curr Atheroscler Rep; 2014 Jun; 16(6):414. PubMed ID: 24777633 [TBL] [Abstract][Full Text] [Related]
8. [Statins and cardiovascular disease prevention: use and prospective]. Moulin P Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617 [No Abstract] [Full Text] [Related]
9. Update on statins and other lipid-lowering drugs. Miller CA Geriatr Nurs; 2001; 22(5):276-7. PubMed ID: 11606910 [No Abstract] [Full Text] [Related]
11. What you should know about: statins. Harv Health Lett; 2012 Oct; 37(12):7. PubMed ID: 23243693 [No Abstract] [Full Text] [Related]
12. [Treatment with statins for the reduction of cardiovascular risk]. Chiariello M Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779 [No Abstract] [Full Text] [Related]
13. Statins: putting the benefit/risk into perspective. Shepherd J Int J Clin Pract Suppl; 2003 Oct; (137):27-33. PubMed ID: 14649699 [No Abstract] [Full Text] [Related]
14. Role of ezetimibe in the prevention of cardiovascular disease: absence of evidence. Mascitelli L; Pezzetta F; Goldstein MR Arch Med Res; 2010 Nov; 41(8):649-50. PubMed ID: 21199735 [TBL] [Abstract][Full Text] [Related]
15. Does the addition of ezetimibe to statins reduce cardiovascular risk? Araya FI; Grassi B Medwave; 2016 Dec; 16(Suppl5):e6632. PubMed ID: 27922588 [TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering therapy and risk of coronary events. Blakely JA JAMA; 2003 Apr 23-30; 289(16):2070-1; author reply 2071-2. PubMed ID: 12709461 [No Abstract] [Full Text] [Related]
17. Lipid-lowering therapy and risk of coronary events. Taylor WC JAMA; 2003 Apr 23-30; 289(16):2070; author reply 2071-2. PubMed ID: 12709462 [No Abstract] [Full Text] [Related]
18. Lipid-lowering therapy and risk of coronary events. Lardinois CK JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709463 [No Abstract] [Full Text] [Related]